Focusing on the SHH pathway, it is known that the mutated and constitutively active KRAS is present in more than 90% of PC, and that it activates NF-ĸB, which directly up-regulates SHH in PC cells (Figure 11) [104]. The gene discussed is KRAS; the disease is pachyonychia congenita.